Migraine Drugs

Migraine Drugs Market by Therapeutic Class (Anti-Nausea Drug, Blood Pressure Lowering Medication, Ergots), Treatment Type (Abortive, Preventive), Route of Administration, Distribution - Global Forecast 2024-2030

360iResearch Analyst
SPEAK TO ANALYST? OR FACE-TO-FACE MEETING?
Want to know more about the migraine drugs market or any specific requirement? Ketan helps you find what you're looking for.
DOWNLOAD A FREE PDF
This free PDF includes market data points, ranging from trend analysis to market estimates & forecasts. See for yourself.

[187 Pages Report] The Migraine Drugs Market size was estimated at USD 4.74 billion in 2023 and expected to reach USD 5.48 billion in 2024, at a CAGR 15.83% to reach USD 13.26 billion by 2030.

Migraine Drugs Market
To learn more about this report, request a free PDF copy
Migraine Drugs Market - Global Forecast 2024-2030
To learn more about this report, request a free PDF copy
FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Migraine Drugs Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Migraine Drugs Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Migraine Drugs Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Aegis Therapeutics, LLC, Alder Biopharmaceuticals, Inc., Allergan Inc. by AbbVie Inc., Amgen, Inc., AstraZeneca Plc, Biohaven, Ltd, Eisai Co., Ltd., Eli Lilly and Company, Endo International Plc, GlaxoSmithKline Plc, H. Lundbeck A/S, Johnson & Johnson Services, Inc., Merck & Co. Inc., Pfizer Inc., Sanofi SA, and Teva Pharmaceuticals Industries Ltd.

Market Segmentation & Coverage

This research report categorizes the Migraine Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Therapeutic Class
    • Anti-Nausea Drug
      • Chlorpromazine
      • Metoclopramide
      • Prochlorperazine
    • Blood Pressure Lowering Medication
      • Beta-Blocker
      • Calcium Channel Blocker
    • Ergots
      • Dihydroergotamines
      • Ergotamine
      • Lasmiditan
    • Opioid Medication
      • OxyContin
      • Percocet
      • Vicodin
    • Pain Reliever
      • Aspirin
      • Ibuprofen
    • Triptans
      • Rizatriptan
      • Sumatriptan
  • Treatment Type
    • Abortive
    • Preventive
  • Route of Administration
    • Injectable
    • Nasal Spray
    • Oral
  • Distribution
    • Hospitals Based Pharmacy
    • Online Pharmacy
    • Retail Pharmacy

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Migraine Drugs Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Migraine Drugs Market?
  3. What are the technology trends and regulatory frameworks in the Migraine Drugs Market?
  4. What is the market share of the leading vendors in the Migraine Drugs Market?
  5. Which modes and strategic moves are suitable for entering the Migraine Drugs Market?

Table of Contents
  1. Preface
  2. Research Methodology
  3. Executive Summary
  4. Market Overview
  5. Market Insights
  6. Migraine Drugs Market, by Therapeutic Class
  7. Migraine Drugs Market, by Treatment Type
  8. Migraine Drugs Market, by Route of Administration
  9. Migraine Drugs Market, by Distribution
  10. Americas Migraine Drugs Market
  11. Asia-Pacific Migraine Drugs Market
  12. Europe, Middle East & Africa Migraine Drugs Market
  13. Competitive Landscape
  14. Competitive Portfolio
  15. List of Figures [Total: 24]
  16. List of Tables [Total: 914]
  17. List of Companies Mentioned [Total: 17]
Frequently Asked Questions
  1. How big is the Migraine Drugs Market?
    Ans. The Global Migraine Drugs Market size was estimated at USD 4.74 billion in 2023 and expected to reach USD 5.48 billion in 2024.
  2. What is the Migraine Drugs Market growth?
    Ans. The Global Migraine Drugs Market to grow USD 13.26 billion by 2030, at a CAGR of 15.83%
  3. When do I get the report?
    Ans. Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
  4. In what format does this report get delivered to me?
    Ans. We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
  5. How long has 360iResearch been around?
    Ans. We are approaching our 7th anniversary in 2024!
  6. What if I have a question about your reports?
    Ans. Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
  7. Can I share this report with my team?
    Ans. Absolutely yes, with the purchase of additional user licenses.
  8. Can I use your research in my presentation?
    Ans. Absolutely yes, so long as the 360iResearch cited correctly.